BANGKOK, April 28 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab has launched its hugely popular weight-loss drug Wegovy in Thailand, an executive of the Danish drugmaker's local subsidiary ...

Thai healthcare solutions company Zuellig Pharma has announced that Mounjaro (tirzepatide), Eli Lilly’s (NYSE: LLY) ...

If you’re exploring diabetes or weight-loss medications, Ozempic and Wegovy have become two popular options of injectable treatments. Both medications support blood sugar control and weight loss ...

Medicare announced Friday that it has selected 15 drugs, including the hugely popular medications Ozempic and Wegovy, used for diabetes and weight loss, as well as some blockbuster cancer ...

Wegovy (semaglutide) is a brand-name subcutaneous injection (shot) prescribed for weight loss and to lower the risk of cardiovascular problems in some people. As with other drugs, Wegovy can cause ...

Customers who struggle to afford the $1,000-plus list price for weight-loss drugs Zepbound and Wegovy will have the option to buy now and pay later under a partnership announced Tuesday by ...

Wegovy (semaglutide) is a weight loss medicine. The FDA first approved Wegovy in 2021 to help people who are overweight or have obesity lose weight and keep it off. In 2024, Wegovy was also ...

The companies will sell the drug at a reduced price of $499 a month. Consumers looking to start the popular weight loss drug Wegovy but lacking insurance coverage will soon have a new option.

The weight-loss drug Wegovy has been bombarding TV commercial breaks with ads, more than a year after its manufacturer, Novo Nordisk, limited starter-dose supplies in the U.S. to get a handle on ...

Wegovy is a brand-name subcutaneous injection prescribed for weight loss and reduction of cardiovascular risks. Its cost with and without insurance can depend on several factors, such as whether ...